Brucke Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Sell
2,463
-45
-2% -$5.93K 0.14% 116
2026
Q1
$350K Sell
2,508
-714
-22% -$100K 0.18% 105
2025
Q4
$396K Sell
3,222
-301
-9% -$36.6K 0.22% 100
2025
Q3
$422K Sell
3,523
-88
-2% -$10K 0.25% 89
2025
Q2
$400K Buy
3,611
+1,322
+58% +$141K 0.28% 87
2025
Q1
$244K Buy
+2,289
New +$236K 0.21% 119

Other funds holding GILD

Brucke Financial's GILD Position: Q2 2026 in Review

Brucke Financial reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $5.93K and leaving 2,463 shares worth $311K. The position accounts for 0.14% of the portfolio, ranked #116.

Brucke Financial first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $422K in Q3 2025. 879 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Brucke Financial held 2,463 shares of Gilead Sciences worth $311K as of Q2 2026.
  • Brucke Financial sold 45 Gilead Sciences shares in Q2 2026, an estimated $5.93K.
  • Gilead Sciences made up 0.14% of Brucke Financial's portfolio in Q2 2026, its #116 holding.
  • Brucke Financial first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Brucke Financial's Gilead Sciences position peaked at $422K in Q3 2025.
  • 879 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Brucke Financial's 13F filing for Q2 2026, filed 21 Jul 2026.